Form D · Pharmaceuticals

Maxona Pharmaceuticals, Inc.

Malvern, PA · CIK 0001857448

Offering snapshot reported Aug 14, 2026 · SEC filing

Reported sold: $5.78M
Investors reported: 56
Minimum accepted: $0
First sale: Jun 4, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$900,163 → $5,778,673
Reported investors15 → 56

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 14, 2026	Amendment	$5,778,673	$4,878,510vs Jun 13, 2025	56	SEC filing
Jun 13, 2025	Initial	$900,163	No comparison	15	SEC filing
May 5, 2021	Initial	$5,555,000	No comparison	34	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $412K
Finders' fees: $0
Form D file number: 021-548944

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Arcadia Securities, LLC	44656

Source: Form D, filed Aug 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Richard Brand	Executive
Shahin Fatholahi	Director, Executive
David Nakamura	Director
Behshad Sheldon	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

101 Lindenwood Drive Suite 225
Malvern, PA, 19355
Phone: 484.681.5626